{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:10:50Z","timestamp":1791486650255,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10689-022-00300-5","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T09:10:07Z","timestamp":1655457007000},"page":"91-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6430-1924","authenticated-orcid":false,"given":"Mitchell L.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jewel","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9293-5860","authenticated-orcid":false,"given":"Rachel","family":"Pearlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-1185","authenticated-orcid":false,"given":"Laith","family":"Abushahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-7853","authenticated-orcid":false,"given":"Amber","family":"Aeilts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-883X","authenticated-orcid":false,"given":"Hui-Zi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Elkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-8677","authenticated-orcid":false,"given":"John","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-0798","authenticated-orcid":false,"given":"Joanne","family":"Jeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-4671","authenticated-orcid":false,"given":"Ning","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9222-4321","authenticated-orcid":false,"given":"Pannaga","family":"Malalur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-3038","authenticated-orcid":false,"given":"Sameek","family":"Roychowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ruple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Prebish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-640X","authenticated-orcid":false,"given":"Peter P.","family":"Stanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-9794","authenticated-orcid":false,"given":"Heather","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"55","key":"300_CR1","first-page":"603","volume":"17","author":"MA Tempero","year":"2019","unstructured":"Tempero MA (2019) NCCN guidelines updates: pancreatic cancer. J Natl Compr Cancer Netw 17(55):603\u2013605","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"300_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM et al (2021) Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 19(1):77\u2013102","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"300_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP et al (2020) Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 38(1):1\u201310","journal-title":"J Clin Oncol"},{"issue":"4","key":"300_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1903387","volume":"381","author":"T Golan","year":"2019","unstructured":"Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ et al (2019) Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer. N Engl J Med 381(4):317\u2013327","journal-title":"N Engl J Med"},{"issue":"24","key":"300_CR5","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1200\/JCO.20.03661","volume":"39","author":"ZK Stadler","year":"2021","unstructured":"Stadler ZK, Maio A, Chakravarty D, Kemel Y, Sheehan M, Salo-Mullen E et al (2021) Therapeutic implications of germline testing in patients with advanced cancers. J Clin Oncol 39(24):2698\u20132709","journal-title":"J Clin Oncol"},{"issue":"2","key":"300_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10689-018-0106-2","volume":"18","author":"EJ Walker","year":"2019","unstructured":"Walker EJ, Carnevale J, Pedley C, Blanco A, Chan S, Collisson EA et al (2019) Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma. Fam Cancer 18(2):241\u2013251","journal-title":"Fam Cancer"},{"issue":"1","key":"300_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12913-018-2957-5","volume":"18","author":"DD Stenehjem","year":"2018","unstructured":"Stenehjem DD, Au T, Sainski AM, Bauer H, Brown K, Lancaster J et al (2018) Impact of a genetic counseling requirement prior to genetic testing. BMC Health Serv Res 18(1):165","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"300_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10897-012-9505-y","volume":"21","author":"SA Cohen","year":"2012","unstructured":"Cohen SA, Gustafson SL, Marvin ML, Riley BD, Uhlmann WR, Liebers SB et al (2012) Report from the national society of genetic counselors service delivery model task force: a proposal to define models, components, and modes of referral. J Genet Couns 21(5):645\u2013651","journal-title":"J Genet Couns"},{"key":"300_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00848-3","author":"C Beard","year":"2021","unstructured":"Beard C, Monohan K, Cicciarelli L, James PA (2021) Mainstream genetic testing for breast cancer patients: early experiences from the Parkville familial cancer centre. Eur J Hum Genetics. https:\/\/doi.org\/10.1038\/s41431-021-00848-3","journal-title":"Eur J Hum Genetics"},{"key":"300_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13334","author":"T Scheinberg","year":"2020","unstructured":"Scheinberg T, Young A, Woo H, Goodwin A, Mahon KL, Horvath LG (2020) Mainstream consent programs for genetic counseling in cancer patients: a systematic review. Asia-Pac J Clin Oncol. https:\/\/doi.org\/10.1111\/ajco.13334","journal-title":"Asia-Pac J Clin Oncol"},{"key":"300_CR11","doi-asserted-by":"publisher","unstructured":"Hamilton JG, Symecko H, Spielman K, Breen K, Mueller R, Catchings A et al (2021) Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. Genetics Med 23(11):2105\u20132113. https:\/\/doi.org\/10.1038\/s41436-021-01262-2","DOI":"10.1038\/s41436-021-01262-2"},{"issue":"11","key":"300_CR12","doi-asserted-by":"publisher","first-page":"e1982","DOI":"10.1002\/onco.13968","volume":"26","author":"EJ Walker","year":"2021","unstructured":"Walker EJ, Goldberg D, Gordon KM, Pedley C, Carnevale J, Cinar P et al (2021) Implementation of an embedded in-clinic genetic testing station to optimize germline testing for patients with pancreatic adenocarcinoma. Oncologist 26(11):e1982\u2013e91","journal-title":"Oncologist"},{"issue":"2","key":"300_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10897-013-9655-6","volume":"23","author":"AM Trepanier","year":"2014","unstructured":"Trepanier AM, Allain DC (2014) Models of service delivery for cancer genetic risk assessment and counseling. J Genet Couns 23(2):239\u2013253","journal-title":"J Genet Couns"},{"issue":"23","key":"300_CR14","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","volume":"319","author":"C Hu","year":"2018","unstructured":"Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY et al (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319(23):2401\u20132409","journal-title":"JAMA"},{"issue":"24","key":"300_CR15","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1002\/cncr.29664","volume":"121","author":"EE Salo-Mullen","year":"2015","unstructured":"Salo-Mullen EE, O\u2019Reilly EM, Kelsen DP, Ashraf AM, Lowery MA, Yu KH et al (2015) Identification of germline genetic mutations in patients with pancreatic cancer. Cancer 121(24):4382\u20134388","journal-title":"Cancer"},{"issue":"2","key":"300_CR16","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1200\/OP.20.00678","volume":"17","author":"A Chittenden","year":"2021","unstructured":"Chittenden A, Haraldsdottir S, Ukaegbu C, Underhill-Blazey M, Gaonkar S, Uno H et al (2021) Implementing systematic genetic counseling and multigene germline testing for individuals with pancreatic cancer. JCO Oncol Pract 17(2):e236\u2013e47","journal-title":"JCO Oncol Pract"},{"key":"300_CR17","unstructured":"Strassberg M. Genetic testing for hereditary cancer. Available from: https:\/\/www.invitae.com\/en\/pretest-video-cancer\/. Accessed 01 June 2021"},{"key":"300_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00871-4","author":"R O\u2019Shea","year":"2021","unstructured":"O\u2019Shea R, Rankin NM, Kentwell M, Gleeson M, Tucker KM, Hampel H et al (2021) Stakeholders\u2019 views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology. Eur J Hum Genetics. 10.1038\/s41431-021-00871-4","journal-title":"Eur J Hum Genetics"},{"issue":"2","key":"300_CR19","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/curroncol28020138","volume":"28","author":"JM McCuaig","year":"2021","unstructured":"McCuaig JM, Thain E, Malcolmson J, Keshavarzi S, Armel SR, Kim RH (2021) A comparison of patient-reported outcomes following consent for genetic testing using an oncologist- or genetic counselor-mediated model of care. Curr Oncol (Toronto Ont) 28(2):1459\u20131471","journal-title":"Curr Oncol (Toronto Ont)"},{"issue":"7","key":"300_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.6004\/jnccn.2020.7546","volume":"18","author":"D Cragun","year":"2020","unstructured":"Cragun D, Weidner A, Tezak A, Zuniga B, Wiesner GL, Pal T (2020) A web-based tool to automate portions of pretest genetic counseling for inherited cancer. J Natl Compr Canc Netw 18(7):841\u2013847","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"300_CR21","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM et al (2019) Consensus guidelines on genetic` testing for hereditary breast cancer from the American society of breast surgeons. Ann Surg Oncol 26(10):3025\u20133031","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"300_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/gim.2014.75","volume":"17","author":"D Cragun","year":"2015","unstructured":"Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C et al (2015) Differences in BRCA counseling and testing practices based on ordering provider type. Genet Med 17(1):51\u201357","journal-title":"Genet Med"},{"issue":"11","key":"300_CR23","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/s41436-021-01262-2","volume":"23","author":"JG Hamilton","year":"2021","unstructured":"Hamilton JG, Symecko H, Spielman K, Breen K, Mueller R, Catchings A et al (2021) Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer. Genet Med 23(11):2105\u20132113","journal-title":"Genet Med"},{"key":"300_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-021-00277-7","author":"K Bokkers","year":"2021","unstructured":"Bokkers K, Zweemer RP, Koudijs MJ, Stehouwer S, Velthuizen ME, Bleiker EMA et al (2021) Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer. Fam Cancer. https:\/\/doi.org\/10.1007\/s10689-021-00277-7","journal-title":"Fam Cancer"},{"key":"300_CR25","doi-asserted-by":"publisher","unstructured":"Heald B, Keel E, Marquard J, Burke CA, Kalady MF, Church JM et al (2020) Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy. J Med Genet 58(12):807\u2013814. https:\/\/doi.org\/10.1136\/jmedgenet-2020-107294","DOI":"10.1136\/jmedgenet-2020-107294"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-022-00300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-022-00300-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-022-00300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:44:46Z","timestamp":1744202686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-022-00300-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s10689-022-00300-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"5 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PPS receives research support from Emtora Biosciences, Freenome Holdings, Janssen Pharmaceuticals Inc., Pfizer Inc. and the PTEN Research foundation. HH is on the scientific advisory boards for Invitae, Promega, and Genome Medical and has stock\/stock options in Genome Medical and GI OnDemand. The remaining authors declare no conflict of interest related to this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This project was reviewed and approved by The Ohio State University Institutional Review Board (protocol 2021E0849).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Given the retrospective nature of this study and minimal risk of reporting aggregate data, a waiver of informed consent was granted by the Institutional Review Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}